Literature DB >> 15490026

Necrotizing enterocolitis in infants: clinical outcome and influence on growth and neurodevelopment.

Ting-Chi Yeh1, Jui-Hsing Chang, Hsin-An Kao, Chyong-Hsin Hsu, Han-Yang Hung, Chun-Chih Peng.   

Abstract

BACKGROUND AND
PURPOSE: Necrotizing enterocolitis (NEC) is a gastrointestinal emergency in neonates. Whether NEC affects infants' growth and development is controversial. The purpose of this study was to explore the clinical characteristics and outcome and to assess the effect of NEC on growth and neurodevelopment in infants.
METHODS: A total of 80 neonates admitted to the neonatal intensive care unit from January 1991 to April 2002 with definite, advanced NEC, including 48 with modified Bell's stage II and 32 with stage III. Sixty six of the patients were premature. Very low birth weight (VLBW) preterm infants without NEC were used as matching controls for the 15 infants with VLBW. The growth and neurodevelopment of patients and controls were assessed using the Bayley Scales of Infant Development-II and compared at 6 and 18 months of corrected age.
RESULTS: NEC developed an average of 27.7 days after feeding began. The most common initial signs were abdominal distension, decreased activity, hematochezia, and abdominal tenderness. Thirty four patients (43%) required surgical intervention. Three infants developed short bowel syndrome after surgical resection. The overall mortality was 24% (19/80) and was mostly associated with extensive bowel involvement and NEC-related sepsis or multiple organ failure. Of the surviving 61 infants, 12 (20%) developed intestinal strictures, 2 in the ileum, 6 in the colon, and 4 in both ileum and colon. Compared with controls, the VLBW infants with NEC were shorter and had delayed psychomotor development at 18 months of corrected age. Mental development, however, did not differ significantly.
CONCLUSIONS: Intestinal stricture was the most common gastrointestinal complication in this series of infants with NEC. Besides the bowel sequelae, VLBW infants who survive NEC are at risk for impairment of growth and neurodevelopment.

Entities:  

Mesh:

Year:  2004        PMID: 15490026

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  13 in total

1.  Does necrotizing enterocolitis affect growth and neurodevelopmental outcome in very low birth weight infants?

Authors:  Dilek Dilli; Zeynep Eras; Hülya Özkan Ulu; Uğur Dilmen; Evrim Durgut Şakrucu
Journal:  Pediatr Surg Int       Date:  2012-01-25       Impact factor: 1.827

2.  Neurodevelopment of extremely preterm infants who had necrotizing enterocolitis with or without late bacteremia.

Authors:  Camilia R Martin; Olaf Dammann; Elizabeth N Allred; Sonal Patel; T Michael O'Shea; Karl C K Kuban; Alan Leviton
Journal:  J Pediatr       Date:  2010-07-02       Impact factor: 4.406

3.  Bacterial DNA content in the intestinal wall from infants with necrotizing enterocolitis.

Authors:  Brian T Bucher; Lucas A McDuffie; Nurmohammad Shaikh; Phillip I Tarr; Barbara B Warner; Aaron Hamvas; Frances V White; Christopher R Erwin; Brad W Warner
Journal:  J Pediatr Surg       Date:  2011-06       Impact factor: 2.545

4.  Evaluation of growth in very low birth weight preterm babies.

Authors:  Serdar Yeşinel; Esin Yıldız Aldemir; Sultan Kavuncuoğlu; Seda Yeşinel; Hayrettin Yıldız
Journal:  Turk Pediatri Ars       Date:  2014-12-01

Review 5.  Neurodevelopmental outcomes of neonates with medically and surgically treated necrotizing enterocolitis.

Authors:  Clare M Rees; Agostino Pierro; Simon Eaton
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-09-19       Impact factor: 5.747

6.  Determining population and developmental pharmacokinetics of metronidazole using plasma and dried blood spot samples from premature infants.

Authors:  Michael Cohen-Wolkowiez; Mario Sampson; Barry T Bloom; Antonio Arrieta; James L Wynn; Karen Martz; Barrie Harper; Gregory L Kearns; Edmund V Capparelli; David Siegel; Daniel K Benjamin; P Brian Smith
Journal:  Pediatr Infect Dis J       Date:  2013-09       Impact factor: 2.129

7.  Very low birth weight preterm infants with surgical short bowel syndrome: incidence, morbidity and mortality, and growth outcomes at 18 to 22 months.

Authors:  Conrad R Cole; Nellie I Hansen; Rosemary D Higgins; Thomas R Ziegler; Barbara J Stoll
Journal:  Pediatrics       Date:  2008-09       Impact factor: 7.124

8.  Safety and effectiveness of meropenem in infants with suspected or complicated intra-abdominal infections.

Authors:  Michael Cohen-Wolkowiez; Brenda Poindexter; Margarita Bidegain; Joern-Hendrik Weitkamp; Robert L Schelonka; David A Randolph; Robert M Ward; Kelly Wade; Gloria Valencia; David Burchfield; Antonio Arrieta; Varsha Mehta; Michele Walsh; Anand Kantak; Maynard Rasmussen; Janice E Sullivan; Neil Finer; Wade Rich; Beverly S Brozanski; John van den Anker; Jeffrey Blumer; Matthew Laughon; Kevin M Watt; Gregory L Kearns; Edmund V Capparelli; Karen Martz; Katherine Berezny; Daniel K Benjamin; P Brian Smith
Journal:  Clin Infect Dis       Date:  2012-09-05       Impact factor: 9.079

9.  Anaerobic antimicrobial therapy after necrotizing enterocolitis in VLBW infants.

Authors:  Julie Autmizguine; Christoph P Hornik; Daniel K Benjamin; Matthew M Laughon; Reese H Clark; C Michael Cotten; Michael Cohen-Wolkowiez; Daniel K Benjamin; P Brian Smith
Journal:  Pediatrics       Date:  2014-12-15       Impact factor: 9.703

10.  Developmental outcome of very low birth weight infants in a developing country.

Authors:  Daynia E Ballot; Joanne Potterton; Tobias Chirwa; Nicole Hilburn; Peter A Cooper
Journal:  BMC Pediatr       Date:  2012-02-01       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.